17q21-q25 aberrations in breast cancer: Combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification

Oncogene

Volumn 18, Issue 46, 1999, Pages 6262-6270

  Orsetti, Béatrice ^a   Courjal, Frank ^a   Cuny, Marguerite ^a   Rodriguez, Carmen ^a   Theillet, Charles ^a  

^a CENTRE VAL D AURELLE   (France)

Author keywords

Amplification; Breast; Cancer; CGH; Chromosome; Imbalance

Indexed keywords

DNA MARKER; REPETITIVE DNA;

ALLELE; ARTICLE; AUTOSOME ABERRATION; BREAST CANCER; CHROMOSOME 17Q; CHROMOSOME LOSS; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL;

EID: 0033523982     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1203006     Document Type: Article

References (28)

1. Bärlund M, Tirkkonen M, Forozan F, Tanner MM, Kallioniemi O and Kallioniemi A. (1997). Gates Chromo. Cancer, 20, 372-376.
2. Bautista S and Theillet C. (1998). Genes Chromo. Cancer, 22, 268-277.
3. Benitez J, Osorio A, Barroso A, Arranz E, Diaz-Guillen MA, Robledo M, Rodriguez de Cordoba S and Heine-Suner D. (1997). Cancer Res., 57, 4217-4220.
4. Bugert P, Von Knobloch R and Kovacs G. (1998). Int. J. Cancer. 76, 337-340.
5. Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zeillinger R, Rodriguez C and Theillet C, (1997). Cancer Res., 57, 4360-4367.
6. Courjal F and Theillet C. (1997). Cancer Res., 57, 4368 4377.
7. Cropp CS, Champeme MH, Lidereau R and Callahan R. (1993). Cancer Res., 53, 5617-5619.
8. Devilee P, van Vliet M, Bardoel A, Kievits T, Kuipers Dijkshoorn N, Pearson PL and Cornelisse CJ. (1991). Cancer Res., 51, 1020-1025.
9. Fletcher J. (1994). In: Methods in Molecular Biology, Vol. 29: Chromosome Analysis Protocols. Godsen J.R. (ed.). Humana Press Inc: Totowa NJ, pp 51-57.
10. Forozan F, Karhu R, Kononen J, Kallioniemi A and Kallioniemi OP. (1997). Trends. Genet., 13, 405-409.
11. Foulkes WD, Black DM, Stamp GW, Solomon E and Trowsdale J. (1993). Int. J. Cancer, 54, 220-225.
12. Isola JJ, Kallioniemi OP, Chu LW, Fuqua SA, Hilsenbeck SG, Osborne CK and Waldman FM. (1995). Am. J. Pathol., 147, 905-911.
13. Jacobs IJ, Smith SA, Wiseman RW, Futreal PA, Harrington T, Osborne RJ, Leech V, Molyneux A, Berchuck A, Ponder BAJ and Bast Jr RC. (1993). Cancer Res., 53, 1218-1221.
14. Kalikin LM, Frank TS, Svoboda-Newman SM, Wetzel JC, Cooney KA and Petty EM. (1997). Oncogene, 14, 1991 1994.
15. Kenek C, Bugert P, Wilhelm M and Kovacs G. (1997). Oncogene, 14, 1093-1098.
16. Kuukasjarvi T, Tanner M, Pennanen S, Karhu R, Visakorpi T and Isola J. (1997). Genes Chromo. Cancer, 18, 94-101.
17. Mitelman F, Mertens F and Johansson B. (1997). Nat. Genet., 15, 417-474.
18. Muleris M, Almeida A, Gerbault-Seureau M, Malfoy B and Dutrillaux B. (1994). Genes Chromo. Cancer, 10, 160-170.
19. Munn KE, Walker RA, Menasce L and Varley JM. (1996). Br. J. Cancer, 73, 636-639.
20. Munn KE, Walker RA and Varley JM. (1995). Oncogene, 10, 1653-1657.
21. Niederacher D, Picard F, Van Roeyen C, An H-X, Bender HG and Beckmann MW. (1997). Genes Chromo. Cancer, 18, 181-192.
22. Plummer SJ, Adams L, Simmons JA and Casey G. (1997a). Oncogene, 14, 2339-2345.
23. Plummer SJ, Paris MJ, Myles J, Tubbs R, Crowe J and Casey G. (1997b). Genes Chromo. Cancer, 20, 354-362.
24. Plummer SJ, Simmons JA, Adams L and Casey G. (1997c). Genomics, 45, 140-146.
25. Rajah R, Valentinis B and Cohen P. (1997). J. Biol. Chem., 272, 12181-12188.
26. Ried T, Just KE, Holtgreve-Grez H, Du Manoir S, Speicher MR, Schröck E, Latham C, Blegen H, Zetterberg A, Cremer T and Auer G. (1995). Cancer Res., 55, 5415-5423.
27. Theile M, Hartmann S, Scherthan H, Arnold W, Deppert W, Frege R, Glaab F, Haensch W and Scherneck S. (1995). Oncogene, 10, 439-447.
28. Wolf M, Aaltonen LA, Szymanska J, Tarkkanen M, Elomaa I and Knuutila S. (1997). Cancer Genet. Cytogenet., 93, 33-38.